|
"pei jer chen"的相關文件
顯示項目 836-860 / 883 (共36頁)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T04:55:57Z |
Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA
|
Huang, L.-R. and Chiu, C.-M. and Yeh, S.-H. and Huang, W.-H. and Hsueh, P.-R. and Yang, W.-Z. and Yang, J.-Y. and Su, I.-J. and Chang, S.-C. and Chen, P.-J.; PO-REN HSUEH; PEI-JER CHEN; SHAN-CHWEN CHANG; SHIOU-HWEI YEH |
| 臺大學術典藏 |
2018-09-10T04:53:00Z |
Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation
|
Chen, C.-H. and Chen, P.-J. and Chu, J.-S. and Yeh, K.-H. and Lai, M.-Y. and Chen, D.-S.; PEI-JER CHEN; KUN-HUEI YEH; DING-SHINN CHEN |
| 臺大學術典藏 |
2018-09-10T04:52:52Z |
Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis
|
Yeh, S.-H.;Tsai, C.-Y.;Kao, J.-H.;Liu, C.-J.;Kuo, T.-J.;Lin, M.-W.;Huang, W.-L.;Lu, S.-F.;Jih, J.;Chen, D.-S.;Chen, P.-J.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; SHIOU-HWEI YEH |
| 臺大學術典藏 |
2018-09-10T04:36:55Z |
Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma.
|
Ming-Whei Yu; Shi-Yi Yang; I-Jen Pan; Chih-Lin Lin; Chun-Jen Liu; Yun-Fan Liaw; Shi-Ming Lin; Pei-Jer Chen; Shou-Dong Lee; Chien-Jen Chen; MING-WHEI YU |
| 臺大學術典藏 |
2018-09-10T04:36:54Z |
Role of Reproductive Factors in Hepatocellular Carcinoma: Impact on Hepatitis B- and C-Related Risk
|
Yu, M.-W.;Chang, H.-C.;Chang, S.-C.;Liaw, Y.-F.;Lin, S.-M.;Liu, C.-J.;Lee, S.-D.;Lin, C.-L.;Chen, P.-J.;Lin, S.-C.;Chen, C.-J.; MING-WHEI YU; CHUN-JEN LIU; PEI-JER CHEN |
| 臺大學術典藏 |
2018-09-10T04:34:11Z |
Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications
|
Chen, P.-J.; Hwang, L.-H.; Chang, L.-Y.; Kao, J.-H.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:34:09Z |
SEN virus infection in patients with chronic hepatitis C: Preferential coinfection with hepatitis C genotype 2a and no effect on response to therapy with interferon plus ribavirin
|
Kao, J.-H.; Chen, W.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:34:08Z |
A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation
|
DING-SHINN CHEN; JIA-HORNG KAO; PEI-JER CHEN; CHUN-JEN LIU; Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chang, C.-F.; Wu, H.-L.; Shau, W.-Y.; Chen, D.-S. |
| 臺大學術典藏 |
2018-09-10T04:34:08Z |
Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers
|
Kao, J.-H.;Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:33:17Z |
Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients
|
Liu, C.-J.;Chen, P.-J.;Lai, M.-Y.;Kao, J.-H.;Jeng, Y.-M.;Chen, D.-S.; CHUN-JEN LIU; YUNG-MING JENG; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:32:21Z |
Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation
|
Lin, M.-T.;Storer, B.;Martin, P.J.;Tseng, L.-H.;Gooley, T.;Chen, P.-J.;Hansen, J.A.; LI-HUI TSENG; PEI-JER CHEN |
| 臺大學術典藏 |
2018-09-10T04:32:21Z |
Interferon-α reduces insulin resistance and β-cell secretion in responders among patients with chronic hepatitis B and C
|
Tai, T.-Y. and Lu, J.-Y. and Chen, C.-L. and Lai, M.-Y. and Chen, P.-J. and Kao, J.-H. and Lee, C.-Z. and Lee, H.-S. and Chuang, L.-M. and Jeng, Y.-M.; HSUAN-SHU LEE; PEI-JER CHEN; YUNG-MING JENG; LEE-MING CHUANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:32:21Z |
Genetic alterations in hepatocellular adenomas [3] (multiple letters)
|
Bioulac-Sage, P. and Laurent-Puig, P. and Balabaud, C. and Zucman-Rossi, J. and Chen, Y.-W. and Chen, Y.-M. and Yeh, S.-H. and Chen, P.-J.; PEI-JER CHEN; SHIOU-HWEI YEH; YUNG-MING CHEN |
| 臺大學術典藏 |
2018-09-10T04:32:21Z |
Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection
|
Fang, Chi?Tai; Chen, Pei-Jer; Chen, Mao-Yuan; Hung, Chien-Ching; Chang, Shan-Chwen; Chang, An-Lung; Chen, Ding-Shinn; Fang, C.-T. and Chen, P.-J. and Chen, M.-Y. and Hung, C.-C. and Chang, S.-C. and Chang, A.-L. and Chen, D.-S.; PEI-JER CHEN; Fang, Chi-Tai; Chen, Pei-Jer; CHI-TAI FANG; SHAN-CHWEN CHANG; Chen, Mao-Yuan; Hung, Chien-Ching; DING-SHINN CHEN; CHIEN-CHING HUNG; Chang, Shan-Chwen; Chang, An-Lung; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T04:17:40Z |
Characterization of integration patterns and flanking cellular sequences of hepatitis B virus in childhood hepatocellular carcinomas
|
Hsu, TY; Ni, YH.; Lin, Y.-C.; Wang, W.-K.; Chen, Y.-C.; Kao, C.-L.; King, C.-C.; Wu-Hsieh, B. A.; Lee, S.-H.; Sung, J.-M.; Yen-Hsuan Ni; Chen, PJ; Chang, MH; Lai, S.-Y.; PEI-JER CHEN; MEI-HWEI CHANG; Chen, C-S.; Tsuei, DJ; Tsuei, DJ;Chang, MH;Chen, PJ;Hsu, TY;Ni, YH.; Tsuei, D.-J. and Chang, M.-H. and Chen, P.-J. and Hsu, T.-Y. and Ni, Y.-H. |
| 臺大學術典藏 |
2018-09-10T04:16:38Z |
Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan.
|
Ming-Whei Yu; Hung-Chuen Chang; Pei-Jer Chen; Chun-Jen Liu; Yun-Fan Liaw; Shi-Ming Lin; Shou-Dong Lee; Shee-Chan Lin; Chih-Lin Lin; Chien-Jen Chen; MING-WHEI YU |
| 臺大學術典藏 |
2018-09-10T04:16:37Z |
Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women
|
Yu, M.-W.;Yang, Y.-C.;Yang, S.-Y.;Chang, H.-C.;Liaw, Y.-F.;Lin, S.-M.;Liu, C.-J.;Lee, S.-D.;Lin, C.-L.;Chen, P.-J.;Lin, S.-C.;Chen, C.-J.; MING-WHEI YU; CHUN-JEN LIU; PEI-JER CHEN |
| 臺大學術典藏 |
2018-09-10T04:14:02Z |
Prevalence and implication of a newly identified infectious agent (SEN virus) in Taiwan
|
JIA-HORNG KAO; DING-SHINN CHEN; PEI-JER CHEN; Kao, J.-H.; Chen, W.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S. |
| 臺大學術典藏 |
2018-09-10T04:14:02Z |
Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection
|
Kao, J.-H.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:14:01Z |
Hepatitis D virus genotypes in intravenous drug users in Taiwan: Decreasing prevalence and lack of correlation with hepatitis B virus genotypes
|
Kao, J.-H.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:14:01Z |
Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C
|
Kao, J.-H.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:13:59Z |
Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C
|
Kao, J.-H.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:13:05Z |
p53 gene and Wnt signaling in benign neoplasms: β-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia
|
Chen, Y.-W. and Jeng, Y.-M. and Yeh, S.-H. and Chen, P.-J.; YUNG-MING JENG; PEI-JER CHEN; SHIOU-HWEI YEH |
| 臺大學術典藏 |
2018-09-10T04:12:18Z |
Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection
|
Kao, J.-H.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:08:23Z |
Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study
|
King, J.K.;Yeh, S.-H.;Lin, M.-W.;Liu, C.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.;Chen, P.-J.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; SHIOU-HWEI YEH |
顯示項目 836-860 / 883 (共36頁)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每頁顯示[10|25|50]項目
|
